Science Explorer Interactive view Map
Company · Chatham · ??

Tonix Pharmaceuticals (United States)

tonixpharma.comROR OpenAlex
Research works
35
▼ 14% vs 2013–17
Citations
1.7k
49.0 per fractional work
Top-10% rate
14.8%
record average 16.5%
Open access
37%
world 28%

Not ranked overall: Tonix Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.59× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 24.11× its world share, 2 worksImmunology and Micro…Neuroscience: 0.24× its world share, 0 worksNeuroscienceComputer Science: 0.10× its world share, 0 worksComputer ScienceMathematics: 1.35× its world share, 0 worksMathematicsMedicine: 2.67× its world share, 4 worksMedicinePsychology: 0.59× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 24.1×. Every wedge is a field page.

Which keywords describe research at Tonix Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Pharmacokinetics, Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Drug Discovery and Diagnostic Criteria.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Inflammation4▲ 4.7×15 topics
  2. Epidemiology3▲ 2.2×13 topics
  3. Cancer3▲ 6.1×9 topics
  4. Pharmacokinetics2▲ 26×2 topics
  5. Glycosylation2▲ 30×2 topics
  6. Monoclonal Antibodies2▲ 43×2 topics
  7. Therapeutic Antibodies2▲ 48×2 topics
  8. Treatment2▲ 4.7×4 topics
  9. Drug Discovery2▲ 15×3 topics
  10. Diagnostic Criteria2▲ 27×3 topics
  11. Immune Response2▲ 8.2×9 topics
  12. Neurobiology2▲ 15×2 topics
  13. Oxidative Stress2▲ 2.8×8 topics
  14. Toxicology2▲ 25×3 topics
  15. Psychological Factors2▲ 25×2 topics
  16. Biomarkers2▲ 7.4×6 topics
  17. Model Organism2▲ 302×1 topic
  18. Zebrafish2▲ 132×1 topic
  19. Central Sensitization2▲ 58×2 topics
  20. Chronic Fatigue Syndrome2▲ 171×1 topic
  21. Fibromyalgia2▲ 171×1 topic
  22. Molecular Docking2▲ 30×2 topics
  23. Antibody Engineering1▲ 40×1 topic
  24. Fc Receptors1▲ 40×1 topic
  25. Genetic Variation1▲ 13×2 topics
  26. Machine Learning1▲ 1.88×2 topics
  27. Drug Target Identification1▲ 53×1 topic
  28. Immunity1▲ 11×3 topics
  29. Virtual Screening1▲ 53×1 topic
  30. Cardiovascular Disease1▲ 2.9×6 topics
  31. Cytochrome P4501▲ 46×1 topic
  32. Drug Metabolism1▲ 63×2 topics
  33. Pharmacogenetics1▲ 83×1 topic
  34. Viral Transmission1▲ 35×3 topics
  35. Angiogenesis1▲ 7.8×6 topics
  36. Immune System1▲ 9.8×2 topics
  37. Vaccine1▲ 8.0×4 topics

Which research topics does Tonix Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Immune cells in cancer, Fibromyalgia and Chronic Fatigue Syndrome Research, Poxvirus research and outbreaks and Galectins and Cancer Biology.

Immune cells in cancer1Immune cells in cancer: 1 fractional worksFibromyalgia and Chronic…0Fibromyalgia and Chronic Fatigue Syndrome Research: 0 fractional worksPoxvirus research and ou…0Poxvirus research and outbreaks: 0 fractional worksGalectins and Cancer Bio…0Galectins and Cancer Biology: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksCancer, Stress, Anesthesia, and Immune Response: 0 fractional worksCOVID-19 Clinical Resear…0COVID-19 Clinical Research Studies: 0 fractional worksBacillus and Francisella bacterial research: 0 fractional worksHerpesvirus Infections and Treatments: 0 fractional worksXenotransplantation and …0Xenotransplantation and immune response: 0 fractional works
ImmunologyPsychiatry and Mental healthVirologyInfectious Diseases3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune cells in cancer Immunology 1 works
  2. 2 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 0 works
  3. 3 Poxvirus research and outbreaks Virology 0 works
  4. 4 Galectins and Cancer Biology Immunology 0 works
  5. 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  6. 6 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works
  7. 7 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  8. 8 Bacillus and Francisella bacterial research Molecular Biology 0 works
  9. 9 Herpesvirus Infections and Treatments Epidemiology 0 works
  10. 10 Xenotransplantation and immune response Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.0%not open63.0%

World: 28% of research is openly available.

with international co-authors10.8%domestic only89.2%

World: 19% is written across borders.

How has Tonix Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 14% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.